236 related articles for article (PubMed ID: 38389839)
41. ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pancreatic cancer.
Li YX; Zhu XX; Wu X; Li JH; Ni XH; Li SJ; Zhao W; Yin XY
Cancer Lett; 2022 Sep; 544():215802. PubMed ID: 35732215
[TBL] [Abstract][Full Text] [Related]
42. Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma.
Pan X; Zhou J; Xiao Q; Fujiwara K; Zhang M; Mo G; Gong W; Zheng L
J Hematol Oncol; 2021 Nov; 14(1):184. PubMed ID: 34727952
[TBL] [Abstract][Full Text] [Related]
43. Macrophages reprogramming driven by cancer-associated fibroblasts under FOLFIRINOX treatment correlates with shorter survival in pancreatic cancer.
Hussain Z; Bertran T; Finetti P; Lohmann E; Mamessier E; Bidaut G; Bertucci F; Rego M; Tomasini R
Cell Commun Signal; 2024 Jan; 22(1):1. PubMed ID: 38167013
[TBL] [Abstract][Full Text] [Related]
44. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
Zhang T; Ren Y; Yang P; Wang J; Zhou H
Cell Death Dis; 2022 Oct; 13(10):897. PubMed ID: 36284087
[TBL] [Abstract][Full Text] [Related]
45. Cysteine depletion induces pancreatic tumor ferroptosis in mice.
Badgley MA; Kremer DM; Maurer HC; DelGiorno KE; Lee HJ; Purohit V; Sagalovskiy IR; Ma A; Kapilian J; Firl CEM; Decker AR; Sastra SA; Palermo CF; Andrade LR; Sajjakulnukit P; Zhang L; Tolstyka ZP; Hirschhorn T; Lamb C; Liu T; Gu W; Seeley ES; Stone E; Georgiou G; Manor U; Iuga A; Wahl GM; Stockwell BR; Lyssiotis CA; Olive KP
Science; 2020 Apr; 368(6486):85-89. PubMed ID: 32241947
[TBL] [Abstract][Full Text] [Related]
46. Modulation of redox metabolism negates cancer-associated fibroblasts-induced treatment resistance in a heterotypic 3D culture platform of pancreatic cancer.
Broekgaarden M; Anbil S; Bulin AL; Obaid G; Mai Z; Baglo Y; Rizvi I; Hasan T
Biomaterials; 2019 Nov; 222():119421. PubMed ID: 31494503
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-8 produced from cancer-associated fibroblasts suppresses proliferation of the OCUCh-LM1 cancer cell line.
Tanaka R; Kimura K; Eguchi S; Ohira G; Tanaka S; Amano R; Tanaka H; Yashiro M; Ohira M; Kubo S
BMC Cancer; 2022 Jul; 22(1):748. PubMed ID: 35804329
[TBL] [Abstract][Full Text] [Related]
48. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
[TBL] [Abstract][Full Text] [Related]
49. circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis.
Hu C; Xia R; Zhang X; Li T; Ye Y; Li G; He R; Li Z; Lin Q; Zheng S; Chen R
Mol Cancer; 2022 Jan; 21(1):24. PubMed ID: 35045883
[TBL] [Abstract][Full Text] [Related]
50. Fibroblast heterogeneity in pancreatic ductal adenocarcinoma: Perspectives in immunotherapy.
Luong T; Golivi Y; Nagaraju GP; El-Rayes BF
Cytokine Growth Factor Rev; 2022 Dec; 68():107-115. PubMed ID: 36096869
[TBL] [Abstract][Full Text] [Related]
51. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
Huang H; Brekken RA
Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
[TBL] [Abstract][Full Text] [Related]
52. Nuclear factor kappa-B contributes to cigarette smoke tolerance in pancreatic ductal adenocarcinoma through cysteine metabolism.
Gunda V; Chhonker YS; Natesh NS; Raut P; Muniyan S; Wyatt TA; Murry DJ; Batra SK; Rachagani S
Biomed Pharmacother; 2021 Dec; 144():112312. PubMed ID: 34678726
[TBL] [Abstract][Full Text] [Related]
53. Pancreatic cancer-derived small extracellular vesical ezrin activates fibroblasts to exacerbate cancer metastasis through STAT3 and YAP-1 signaling pathways.
Chang YT; Peng HY; Hu CM; Tien SC; Chen YI; Jeng YM; Chang MC
Mol Oncol; 2023 Aug; 17(8):1628-1647. PubMed ID: 37171030
[TBL] [Abstract][Full Text] [Related]
54. The Lin28b/Wnt5a axis drives pancreas cancer through crosstalk between cancer associated fibroblasts and tumor epithelium.
Shu Z; Fan M; Tu B; Tang Z; Wang H; Li H; Li H; Yuan M; Bai J; Huo S; Wang L; Zhu WG; Wang W; Liu X; Shu S; Zhao Y
Nat Commun; 2023 Oct; 14(1):6885. PubMed ID: 37898598
[TBL] [Abstract][Full Text] [Related]
55. Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-β1/SMAD2/3 pathway and ABCC1 transactivation.
Wei L; Lin Q; Lu Y; Li G; Huang L; Fu Z; Chen R; Zhou Q
Cell Death Dis; 2021 Mar; 12(4):334. PubMed ID: 33782384
[TBL] [Abstract][Full Text] [Related]
56. Pancreatic cancer stroma: an update on therapeutic targeting strategies.
Hosein AN; Brekken RA; Maitra A
Nat Rev Gastroenterol Hepatol; 2020 Aug; 17(8):487-505. PubMed ID: 32393771
[TBL] [Abstract][Full Text] [Related]
57. Tumor-stromal cross-talk modulating the therapeutic response in pancreatic cancer.
Neumann CCM; von Hörschelmann E; Reutzel-Selke A; Seidel E; Sauer IM; Pratschke J; Bahra M; Schmuck RB
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):461-472. PubMed ID: 30243879
[TBL] [Abstract][Full Text] [Related]
58. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
[TBL] [Abstract][Full Text] [Related]
59. Tumor-stroma TGF-β1-THBS2 feedback circuit drives pancreatic ductal adenocarcinoma progression via integrin α
Nan P; Dong X; Bai X; Lu H; Liu F; Sun Y; Zhao X
Cancer Lett; 2022 Mar; 528():59-75. PubMed ID: 34958892
[TBL] [Abstract][Full Text] [Related]
60. Subtypes in pancreatic ductal adenocarcinoma based on niche factor dependency show distinct drug treatment responses.
Shinkawa T; Ohuchida K; Mochida Y; Sakihama K; Iwamoto C; Abe T; Ideno N; Mizuuchi Y; Shindo K; Ikenaga N; Moriyama T; Nakata K; Oda Y; Nakamura M
J Exp Clin Cancer Res; 2022 Mar; 41(1):89. PubMed ID: 35272688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
